Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NCSM
|
Marty Stromquist
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,038 Added 24.51% |
-
|
Mar 02
2022 |
NCSM
|
Tim Willems
Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,563 Added 25.97% |
-
|
Mar 02
2022 |
VGZ
|
Douglas L. Tobler
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 82,769 Reduced 28.98% |
$69,526
$0.84 p/Share
|
Mar 02
2022 |
VGZ
|
Douglas L. Tobler
CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 185,657 Added 39.39% |
-
|
Mar 02
2022 |
VGZ
|
Frederick Hume Earnest
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 156,420 Reduced 8.28% |
$131,393
$0.84 p/Share
|
Mar 02
2022 |
VGZ
|
Frederick Hume Earnest
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 346,498 Added 15.5% |
-
|
Mar 02
2022 |
VGZ
|
John W. Rozelle
Former Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 47,680 Reduced 7.42% |
$40,051
$0.84 p/Share
|
Mar 02
2022 |
VGZ
|
John W. Rozelle
Former Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 130,000 Added 16.82% |
-
|
Mar 02
2022 |
VGZ
|
Pamela A. Solly
VP, Investor Relations |
SELL
Payment of exercise price or tax liability
|
Direct | 29,434 Reduced 16.35% |
$24,725
$0.84 p/Share
|
Mar 02
2022 |
VGZ
|
Pamela A. Solly
VP, Investor Relations |
BUY
Exercise of conversion of derivative security
|
Direct | 79,554 Added 30.65% |
-
|
Mar 02
2022 |
CPS
|
Stephen A Van Oss
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 25.69% |
$256,400
$12.82 p/Share
|
Mar 02
2022 |
PBYI
|
Alan H Auerbach
President and CEO |
SELL
Open market or private sale
|
Direct | 1,294 Reduced 0.03% |
$2,924
$2.26 p/Share
|
Mar 02
2022 |
PBYI
|
Douglas M Hunt
Officer |
SELL
Open market or private sale
|
Direct | 446 Reduced 0.74% |
$1,008
$2.26 p/Share
|
Mar 02
2022 |
PBYI
|
Maximo F Nougues
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 169 Reduced 0.28% |
$382
$2.26 p/Share
|
Mar 02
2022 |
PBHC
|
Ronald Tascarella
Retired Executive Vice Pres. |
SELL
Open market or private sale
|
Direct | 4,988 Reduced 7.84% |
$87,789
$17.6 p/Share
|
Mar 02
2022 |
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 25,000 Added 1.35% |
$397,250
$15.89 p/Share
|
Mar 02
2022 |
FNWD
|
Leane English Cerven
Executive Vice President |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 17.72% |
$91,280
$45.64 p/Share
|
Mar 02
2022 |
AUD
|
Susan K Neely
Director |
BUY
Open market or private purchase
|
Direct | 3,175 Added 3.02% |
$9,842
$3.1 p/Share
|
Mar 02
2022 |
FFNW
|
Ronnie J Clariza
Senior VP/ CRO of the Bank |
BUY
Grant, award, or other acquisition
|
Direct | 2,896 Added 9.29% |
$49,029
$16.93 p/Share
|
Mar 02
2022 |
FFNW
|
Dalen D Harrison
Sr. VP/CBO of the Bank |
BUY
Grant, award, or other acquisition
|
Direct | 3,489 Added 12.33% |
$59,069
$16.93 p/Share
|
Mar 02
2022 |
FFNW
|
Christine A. Huestis
1st VP/Prin Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,998 Added 30.24% |
$33,826
$16.93 p/Share
|
Mar 02
2022 |
FFNW
|
Richard P Jacobson
Executive VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 5,256 Added 13.84% |
$88,984
$16.93 p/Share
|
Mar 02
2022 |
FFNW
|
Joseph W Kiley Iii
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 12,726 Added 24.11% |
$215,451
$16.93 p/Share
|
Mar 02
2022 |
FFNW
|
Simon Soh
Senior VP/CCO of the Bank |
BUY
Grant, award, or other acquisition
|
Direct | 3,593 Added 8.91% |
$60,829
$16.93 p/Share
|
Mar 02
2022 |
PSNL
|
Aaron Tachibana
CFO AND COO |
SELL
Open market or private sale
|
Direct | 4,511 Reduced 1.76% |
$45,922
$10.18 p/Share
|
Mar 02
2022 |
PSNL
|
Richard Chen
CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct | 471 Reduced 0.3% |
$4,795
$10.18 p/Share
|
Mar 02
2022 |
PSNL
|
Lightspeed Venture Partners Select Iv, L.P. |
BUY
Open market or private purchase
|
Indirect | 48,989 Added 2.62% |
$487,930
$9.96 p/Share
|
Mar 02
2022 |
WNEB
|
Kevin C O'Connor
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,977 Added 12.44% |
-
|
Mar 02
2022 |
WNEB
|
Philip R Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 13.47% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Laura Benoit
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 5.51% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Donna J. Damon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 3.65% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Gary G Fitzgerald
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 9.31% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Lisa G Mc Mahon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 4.85% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
William D Masse
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 3.65% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Gregg F Orlen
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,975 Added 5.56% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Paul C Picknelly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 2.2% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
Steven G. Richter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,975 Added 4.41% |
$17,992
$9.11 p/Share
|
Mar 02
2022 |
WNEB
|
John E Bonini
SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 2,420 Added 28.03% |
-
|
Mar 02
2022 |
WNEB
|
Louis O Gorman Iii
SVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,463 Added 10.0% |
-
|
Mar 02
2022 |
WNEB
|
James C Hagan
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 12,386 Added 6.08% |
-
|
Mar 02
2022 |
WNEB
|
Darlene M Libiszewski
SVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,432 Added 13.65% |
-
|
Mar 02
2022 |
WNEB
|
Allen J Miles Iii
EVP & Chief Lending Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,688 Added 16.72% |
-
|
Mar 02
2022 |
WNEB
|
Christine Phillips
SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,332 Added 25.73% |
-
|
Mar 02
2022 |
WNEB
|
Leo R Sagan Jr
SVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,591 Added 33.22% |
-
|
Mar 02
2022 |
WNEB
|
Guida R Sajdak
EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 3,295 Added 10.5% |
-
|
Mar 02
2022 |
MIXT
|
Ian Jacobs
Director |
BUY
Open market or private purchase
|
Indirect | 651,275 Added 3.46% |
$306,099
$0.47 p/Share
|
Mar 02
2022 |
SPNE
|
Keith Bradley
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 37 Reduced 0.05% |
$490
$13.25 p/Share
|
Mar 02
2022 |
NATR
|
Terrence Moorehead
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,389 Reduced 0.63% |
$41,616
$17.42 p/Share
|
Mar 02
2022 |
NATR
|
Terrence Moorehead
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,804 Added 2.52% |
-
|
Mar 02
2022 |
NATR
|
Joseph W Baty
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,226 Reduced 0.8% |
$21,357
$17.42 p/Share
|
Mar 02
2022 |